TickerFactsScreenerDevelopers

Vir Biotechnology, Inc. (VIR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$66.38M2018: -$94.10M2019: -$129.63M2020: -$190.94M2021: -$47.59M2022: $1.66B2023: -$778.78M2024: -$446.35M2025: -$391.78M-$391.78M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$391.78M+12.2%
2024-$446.35M+42.7%
2023-$778.78M-146.8%
2022$1.66B+3595.0%
2021-$47.59M+75.1%
2020-$190.94M-47.3%
2019-$129.63M-37.8%
2018-$94.10M-41.8%
2017-$66.38M—